PLAUR and head and neck squamous cell carcinoma: Pre-treatment plasma uPAR did not predict RFS nor OS in HNSCC patients referred to curatively intended radiotherapy, in contrast to pre-treatment uPAR-PET/CT, which has previously been shown to predict RFS.